Pretreatment with insulin-like growth factor I protects skeletal muscle cells against oxidative damage via PI3K/Akt and ERK1/2 MAPK pathways
- 1 March 2010
- journal article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 90 (3), 391-401
- https://doi.org/10.1038/labinvest.2009.139
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- SLIMMER (FHL1B/KyoT3) Interacts with the Proapoptotic Protein Siva-1 (CD27BP) and Delays Skeletal Myoblast ApoptosisJournal of Biological Chemistry, 2009
- IGF-I activates caspases 3/7, 8 and 9 but does not induce cell death in colorectal cancer cellsBMC Cancer, 2009
- Apoptotic signaling induced by H2O2-mediated oxidative stress in differentiated C2C12 myotubesLife Sciences, 2009
- Calpain-1 is required for hydrogen peroxide-induced myotube atrophyAmerican Journal of Physiology-Cell Physiology, 2009
- Regulation of muscle mass by growth hormone and IGF‐IBritish Journal of Pharmacology, 2008
- Slow- and fast-twitch rat hind limb skeletal muscle phenotypes 8 months after spinal cord transection and olfactory ensheathing glia transplantationThe Journal of Physiology, 2008
- Inducing apoptosis of human colon cancer cells by an IGF-I D domain analogue peptideMolecular Cancer, 2008
- Genetic Deficiency of p38α Reveals its Critical Role in Myoblast Cell Cycle Exit:The p38α-JNK ConnectionCell Cycle, 2007
- PI3K/Akt and apoptosis: size mattersOncogene, 2003
- Prevention of cytokine-induced apoptosis by insulin-like growth factor-I is independent of cell adhesion molecules in HT29-D4 colon carcinoma cells–evidence for a NF-κB-dependent survival mechanismCell Death & Differentiation, 2002